Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APPITD in Type 2 Diabetes
NCT07118475Phase 1Enrolling by invitation
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Oct 2025
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in type 2 diabetes mellitus (T2DM), sponsored by Zhongshan Hospital, Fudan University. Primary endpoints: Number of participants with treatment-related adverse events as assessed by CTCAE v5.0 at 1 year and Hypoglycemia incidence rate at 1 year. Started Oct 2025; status: enrolling by invitation.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07118475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07118475.